However, subsequent studies (Acha-Sagredo et al., 2020; Tang et al., 2021; Wang B. et al., 2022)have shown that PCAT19 is significantly downregulated in lung cancer, including NSCLC and lung adenocarcinoma (LUAD). This evidence concerns the gene PCAT19 and lung carcinoma.